Patent On AIDS Medicine Denied In India

The decision was not based on a controversial article of Indian law aimed at preventing patent extensions but rather on the grounds of non-inventiveness. Abbott Laboratories, meanwhile, presented Intellectual Property Watch with justification for its Indian patent request.
The HIV combination drug ritonavir/lopinavir was
Full Story: Patent On AIDS Medicine Denied In India